Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP Highlights Its HIFU and Lithotripsy Technologies at 109th Annual AUA Meeting
Receives Outstanding Poster Designation for Ablatherm-HIFU
View HTML
Toggle Summary EDAP Highlights Innovative Sonolith i-move Lithotripter at the Annual Japanese Urological Association Meeting
EDAP Pursues Lithotripsy Expansion Strategy
View HTML
Toggle Summary EDAP Highlights HIFU Focal Therapy for Treatment of Prostate Cancer
Ablatherm-HIFU Highlighted as Superior Non-Invasive Focal Therapy; Awarded Best Poster for Long-Term Focal Therapy Results
View HTML
Toggle Summary EDAP Highlights HIFU Expertise at Third International Symposium on Focused Ultrasound in Washington, D.C.
Expanding Interest for HIFU Use in Treating Prostate and Liver Cancer
View HTML
Toggle Summary EDAP Highlights HIFU Expertise at 7th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer
LYON, France , Aug. 26, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced its participation in the Seventh International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer, which took place in Los Angeles , August 21-23,
View HTML
Toggle Summary EDAP Highlights Business Progress in Europe
Recent Marketing Initiatives Result in 40% Growth in RPP Treatments
View HTML
Toggle Summary EDAP Highlights Ablatherm-HIFU and Sonolith I-Sys Technologies At French Association of Urology Annual Meeting
LYON, France, Nov 26, 2008 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it showcased the Ablatherm-HIFU technology and next generation Sonolith I-Sys device at the French Association of Urology (AFU) Annual
View HTML
Toggle Summary EDAP Highlights Ablatherm-HIFU and Sonolith I-Sys Devices At European Association of Urology Congress
Sales and Marketing Initiatives Continue to Drive Product Adoption
View HTML
Toggle Summary EDAP Highlights Ablatherm-HIFU and Sonolith i-move at European Association of Urology Conference
Launches Sonolith i-move Lithotripsy Device Ablatherm-HIFU Featured as Superior Technology
View HTML
Toggle Summary Edap Highlights Ablatherm Munich-based Harlaching Hospital as the Leading Treatment Center in 2007
45% Year-Over-Year Treatment Growth Continues to Drive Adoption At Munich Center
View HTML